Literature DB >> 11511566

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.

S Barrett1, J Goh, B Coughlan, E Ryan, S Stewart, A Cockram, J C O'Keane, J Crowe.   

Abstract

BACKGROUND/AIMS: The cohort of Irish women infected with hepatitis C virus (HCV) genotype 1b via contaminated anti-D immunoglobulin in 1977 represent a unique homogenous group to investigate the natural course of HCV infection.
METHODS: The clinical status of 87 polymerase chain reaction (PCR) positive and 68 PCR negative women was investigated at diagnosis (1994/95) and after 4-5 years of follow up (21/22 years after inoculation). Other features investigated included: histological status/progression, psychosocial impact of HCV infection, extrahepatic manifestations, and HLA class II associations.
RESULTS: The most common symptoms reported were fatigue and arthralgia. Furthermore, 77% of women fell within the clinical range for psychological distress. A history of icteric hepatitis was reported in 20.6% of PCR negative and 3.4% of PCR positive women after inoculation (p=0.002). The mean histological activity index/fibrosis scores of PCR positive and negative women were 4.1 (1.4)/1.1 (1.3) and 2.1 (1.5)/0.15 (0.36) at diagnosis and 4.1 (1.2)/1.0 (1.0) in 44 PCR positive women after five years of follow up. Cirrhosis or hepatocellular carcinoma was not observed. The DRB1*01 allele was present in 28.8% of PCR negative and 8.7% of PCR positive women (p=0.004). The prevalence rates of mixed cryoglobulinaemia, sicca complex, positive thyroid autoantibodies, antinuclear antibody, rheumatoid factor, and antimitochondrial antibody in PCR positive women were 12.7%, 7.6%, 13.9%, 5.1%, 3.8%, and 3.8%.
CONCLUSIONS: A benign course of HCV infection with lack of disease progression was observed in women with chronic HCV, 22 years after inoculation. Acute icteric hepatitis and the HLA DRB1*01 allele were associated with viral clearance. Despite this favourable outcome, high levels of psychological distress and poor quality of life were present.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511566      PMCID: PMC1728443          DOI: 10.1136/gut.49.3.423

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection.

Authors:  S Sachithanandan; J F Fielding
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-01       Impact factor: 2.566

2.  Lack of epidemiological evidence for a link between thyroid auto-immune disease and hepatitis C virus infection.

Authors:  E Gorez; I Nakib; H Larbre; N Schneider; C Schvartz; M J Delisle; B Delemer; J Caron; G Thiéfin
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

3.  Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.

Authors:  B Soto; A Sánchez-Quijano; L Rodrigo; J A del Olmo; M García-Bengoechea; J Hernández-Quero; C Rey; M A Abad; M Rodríguez; M Sales Gilabert; F González; P Mirón; A Caruz; F Relimpio; R Torronteras; M Leal; E Lissen
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

4.  Morbidity of chronic hepatitis C as seen in a tertiary care medical center.

Authors:  D H Lee; H Jamal; F G Regenstein; R P Perrillo
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

5.  Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

Authors:  P H McGuinness; G A Bishop; D M Painter; R Chan; G W McCaughan
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

6.  The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses.

Authors:  M Kobayashi; E Tanaka; T Sodeyama; A Urushihara; A Matsumoto; K Kiyosawa
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

7.  Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.

Authors:  G R Foster; R D Goldin; H C Thomas
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

8.  Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.

Authors:  T L Fong; S R Lee; W K Briggs; B Valinluck; S Govindarajan; A Hoffman; B Jaczko; A G Redeker
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

9.  Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.

Authors:  V S Wong; W Egner; T Elsey; D Brown; G J Alexander
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

Review 10.  Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations.

Authors:  S C Gumber; S Chopra
Journal:  Ann Intern Med       Date:  1995-10-15       Impact factor: 25.391

View more
  33 in total

1.  Hepatitis C update.

Authors:  Shimian Zou; Leslie Forrester; Antonio Giulivi
Journal:  Can J Public Health       Date:  2003 Mar-Apr

2.  Making the best of a bad situation: early chronic nosocomial HCV infection.

Authors:  Carmi Santos; Steven K Herrine
Journal:  Dig Dis Sci       Date:  2010-05-18       Impact factor: 3.199

3.  Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors:  Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.

Authors:  Timothy L Mosbruger; Priya Duggal; James J Goedert; Gregory D Kirk; W Keith Hoots; Leslie H Tobler; Michael Busch; Marion G Peters; Hugo R Rosen; David L Thomas; Chloe L Thio
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 5.  Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

Authors:  D M Forton
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

6.  Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.

Authors:  Xin Hong; Rong-Bin Yu; Nan-Xiong Sun; Bin Wang; Yao-Chu Xu; Guan-Ling Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

7.  Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

Authors:  K Weissenborn; J C Ennen; M Bokemeyer; B Ahl; U Wurster; H Tillmann; C Trebst; H Hecker; G Berding
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

8.  Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients.

Authors:  S Mascheretti; H Hinrichsen; S Ross; P Buggisch; J Hampe; U R Foelsch; S Schreiber
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Liver fibrosis progression in hepatitis C virus infection after seroconversion.

Authors:  Adeel A Butt; Peng Yan; Vincent Lo Re; David Rimland; Matthew B Goetz; David Leaf; Matthew S Freiberg; Marina B Klein; Amy C Justice; Kenneth E Sherman
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

10.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.